Barbara Helen Smith Chair in Preventive & Behavioral Medicine
Tufts University School of Medicine, Biomedical Sciences
Population and Quantitative Health Sciences
myIDP, an interactive career planning tool at ScienceCareers
Center for Biomedical Career Development
Prevention Research Center at UMass Chan
Chengzhi Du, PhD. Chengzhi received his PhD degree in Cancer Biology in 2019 from Institute of Biophysics, Chinese Academy of Sciences, Beijing. Since then, he joined Zhong Lab as a Postdoctoral Associate, initially at Peking University Shenzhen Graduate School, then moved with the lab to UMass Chan Medical School (5/20/2023-).
Mengjia Lu, PhD. Mengjia was a graduate student in Zhong Lab. She joined the lab in late 2019 and received her PhD degree in Chemical Genomics in July 2023 from Peking University, China. As the lab then moved to UMass Chan Medical School, she rejoined the lab at UMass Med as a Postdoctoral Associate (10/16/2023-).
Postdoctoral Positions Available We are seeking highly motivated postdoctoral researchers with a strong background in cellular and molecular biology, molecular physiology, RNA biology/biochemistry, or related fields in biological and biomedical sciences. Prior research experience in metabolic disease molecular physiology/therapy or cancer immunotherapies is highly desirable. To apply, please submit a cover letter and CV listing three references by email to Guocai Zhong at Guocai.Zhong@umassmed.edu.
Rotation projects are available in the three areas of our lab's current research interests.
Fox EC, Wang K, Aquino M, Grandner MA, Xie D, Branas CC, Gooneratne NS
Fox EC, Wang K, Aquino M, Grandner MA, Xie D, Branas CC, Gooneratne NS. Sleep debt at the community level: impact of age, sex, race/ethnicity and health. Sleep Health. 2018 08; 4(4):317-324.
Sleep debt at the community level: impact of age, sex, race/ethnicity and health.
Domouzoglou EM, Fisher FM, Astapova I, Fox EC, Kharitonenkov A, Flier JS, Hollenberg AN, Maratos-Flier E
Domouzoglou EM, Fisher FM, Astapova I, Fox EC, Kharitonenkov A, Flier JS, Hollenberg AN, Maratos-Flier E. Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo. Endocrinology. 2014 May; 155(5):2031-40.
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo.
Spritzer MD, Fox EC, Larsen GD, Batson CG, Wagner BA, Maher J
Spritzer MD, Fox EC, Larsen GD, Batson CG, Wagner BA, Maher J. Testosterone influences spatial strategy preferences among adult male rats. Horm Behav. 2013 May; 63(5):800-12.
Testosterone influences spatial strategy preferences among adult male rats.
Fox EC, Manchala V. Retropharyngeal Hematoma as an Unusual Presentation of Myelodysplastic Syndrome: A Case Report. Am J Case Rep. 2018 Aug 17; 19:969-972.
Retropharyngeal Hematoma as an Unusual Presentation of Myelodysplastic Syndrome: A Case Report.
Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM
Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM. FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012 Feb 01; 26(3):271-81.
FGF21 regulates PGC-1a and browning of white adipose tissues in adaptive thermogenesis.
Joseph D. Early Chair in Biomedical Research
Prevention Strategies for Second Primary Malignancies After CAR-T Therapy
The Darkest Side of AML: The TP53 Mutation
Clonal Hematopoiesis in Clinical Practice: Real-World Insights
Unpacking CHIP: Recent Updates, Remaining Questions
Dr Patel on the Impact of Donor-Engrafted Clonal Hematopoiesis on Outcomes With Auto-/Allo-HSCT
Effects of donor-engrafted clonal hematopoiesis in stem cell transplantation
High-Risk Myelodysplastic Syndrome Findings in the SELECT-MDS-1 Study
Stem Cell Transplantation: How Clonal Hematopoiesis Shapes Patient Outcomes
Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients
The Impact of Mutations in Clonal Hematopoiesis
TP53 in MDS & AML Prognostication & Treatment Strategies
Exploring the Biological Basis of TP53-Aberrant MDS & AML
Improving Outcomes in Blast Phase Chronic Myeloid Leukemia
ASH Clinical News - Practical Solutions Amid Cuts to Federally Funded Research
OncLive with Dr. Patel and Dr. Gerber: p53 Immunohistochemistry
Early Identification of TP53-Mutant MDS and AML Using p53 Immunostaining
Point-of-Care p53 IHC Unveils TP53-Mutant MDS/AML
IHC Enables Rapid Identification of TP53-Mutant MDS/AML
ASH Clinical News: p53 Immunohistochemistry for TP53-Mutant MDS/AML
p53 Immunostain in TP53-Mutant MDS and AML